Clinical subtypes in Parkinson's disease: The impact of MAPT haplotypes

Journal of Neural Transmission

Volumn 121, Issue 4, 2014, Pages 353-356

  Di Battista, Maria Elena ^a   Pascale, Esterina ^b   Purcaro, Carlo ^a   Passarelli, Francesca ^b   Passarelli, Emanuela ^b   Guglielmi, Renzo ^a   Vanacore, Nicola ^c   Meco, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

MAPT haplotypes; Parkinson's disease subtypes

Indexed keywords

AGED; DNA MUTATIONAL ANALYSIS; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TAU PROTEINS; TREMOR;

EID: 84898899860     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1117-7     Document Type: Article

References (12)

1. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197-211
2. Charlesworth G, Gandhi S, Bras JM, Barker RA, Burn DJ, Chinnery PF et al (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiol Aging 33(4):838e7-838e11
3. Eggers C, Pedrosa DJ, Kahraman D, Maier F, Lewis CJ, Fink GR et al (2012) Parkinson subtypes progress differently in clinical course and imaging pattern. PLoS One 7(10):e46813
4. Jellinger KA (2012) CSF biomarkers in different phenotypes of Parkinson disease. J Neural Transm 119(4):455-456
5. Marras C, Lang A (2013) Parkinson's disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry 84(4):409-415
6. Poulopoulos M, Levy OA, Alcalay RN (2012) The neuropathology of genetic Parkinson's disease. Mov Disord 27(7):831-842
7. Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R (2009) Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with parkinson's disease. BMC Neurology 9:26
8. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson's disease. Brain 132(11):2947-2957
9. van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E (2012) Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease. Parkinsonism Relat Disord 18(Suppl 1):S28-S30
10. Wade-Martins R (2012) Genetics: the MAPT locus-a genetic paradigm in disease susceptibility. Nat Rev Neurol 8(9):477-478
11. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW et al (2009) The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 132(11):2958-2969
12. Zhang J, Song Y, Chen H, Fan D (2005) The tau gene haplotype H1 confers a susceptibility to Parkinson's disease. Eur Neurol 53(1):15-21